Geneva Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Geneva Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$18K	–	821
2016 Q3	$18K	Hold	1,000	–	–	﹤0.01%	729
2016 Q2	$17K	Hold	1,000	–	–	﹤0.01%	690
2016 Q1	$20K	Hold	1,000	–	–	﹤0.01%	686
2015 Q4	$19K	Hold	1,000	–	–	﹤0.01%	641
2015 Q3	$19K	Buy	+1,000	New	+$34K	﹤0.01%	617
2014 Q4	–	Sell	-2,420	Closed	-$101K	–	750
2014 Q3	$101K	Buy	+2,420	New	+$108K	﹤0.01%	619
2014 Q1	–	Sell	-1,000	Closed	-$59K	–	709
2013 Q4	$59K	Hold	1,000	–	–	﹤0.01%	513
2013 Q3	$53K	Buy	+1,000	New	+$67.1K	﹤0.01%	483

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Geneva Advisors's ARNA Position: Q4 2016 in Review

Geneva Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2016, closing a stake of 1,000 shares — an estimated $18K sold.

Geneva Advisors first reported a position in ARNA in Q3 2013 and held it in 8 quarters. The position peaked at $101K in Q3 2014. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

Geneva Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Geneva Advisors sold 1,000 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $18K.
Geneva Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
Geneva Advisors's Arena Pharmaceuticals Inc position peaked at $101K in Q3 2014.
128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.